Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Med Decis Making. 2009 Jan-Feb;29(1):91-103. doi: 10.1177/0272989X08323298. Epub 2009 Jan 13.

Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose.

Author information

  • 1School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA. rahansen@unc.edu

Abstract

PURPOSE:

To describe a method for quantitatively dealing with drug dose in comparative effectiveness reviews. Second-generation antidepressants are used as an example to illustrate this method and to determine whether dose influences conclusions on comparative effectiveness.

METHODS:

Studies previously identified in a systematic review of second-generation antidepressants were included if data on drug dose were available. The usual dosing range for each drug was defined and then used to create 2- and 3-level dose categories. Placebo-controlled data were used to calculate overall effect sizes for the drug class and effect sizes stratified by drug dose. Meta-regression tested the impact of dose on effect size. Weighted mean differences and risk ratios were calculated for comparative studies, stratifying by whether compared doses were equivalent.

RESULTS:

The dose classification method was able to identify dose-response trends in the context of meta-analysis. Compared to low-dose studies, medium- and high-dose studies had a 1- to 2-point greater differential in mean Hamilton Depression Rating Scale (HAM-D) change (P < 0:001). Dose was not a statistically significant predictor of categorical HAM-D response. Among comparative trials with nonequivalent doses, trends favored higher dose categories but generally were not statistically significant.

CONCLUSIONS:

A structured method for quantitatively dealing with drug dose in comparative effectiveness reviews is described, with application to the second-generation antidepressants. Dose-dependent reductions in HAM-D scores were identified, although differences did not translate into better response rates for higher doses. Dose equivalency was not a significant factor among comparative studies in second-generation antidepressants.

PMID:
19141788
[PubMed - indexed for MEDLINE]
PMCID:
PMC2657322
Free PMC Article

Images from this publication.See all images (5)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk